BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18309953)

  • 1. Bilateral panocular involvement with mantle-cell lymphoma.
    Chappelow AV; Singh AD; Perez VL; Lichtin A; Pohlman B; Macklis R
    J Clin Oncol; 2008 Mar; 26(7):1167. PubMed ID: 18309953
    [No Abstract]   [Full Text] [Related]  

  • 2. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular involvement of Mantle cell lymphoma: A case report and literature review.
    Iqbal M; Castano YG; Sher T; Kharfan-Dabaja MA
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):147-152. PubMed ID: 30978309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapies for mantle cell lyphoma.
    Williams ME
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):708, 11. PubMed ID: 16258472
    [No Abstract]   [Full Text] [Related]  

  • 5. Mantle cell lymphoma: established therapeutic options and future directions.
    Lenz G; Dreyling M; Hiddemann W
    Ann Hematol; 2004 Feb; 83(2):71-7. PubMed ID: 14669040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody therapy in hematology and oncology - part 1].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214
    [No Abstract]   [Full Text] [Related]  

  • 7. Current management of mantle cell lymphoma.
    Weigert O; Unterhalt M; Hiddemann W; Dreyling M
    Drugs; 2007; 67(12):1689-702. PubMed ID: 17683170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mantle cell lymphoma of the iris.
    Economou MA; Kopp ED; All-Ericsson C; Seregard S
    Acta Ophthalmol Scand; 2007 May; 85(3):341-3. PubMed ID: 17488468
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraocular mantle cell lymphoma of the iris.
    Reid JP; Puglis CL; Slagle WS
    Optom Vis Sci; 2014 Apr; 91(4 Suppl 1):S25-9. PubMed ID: 24637484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma.
    Lim SH; Esler WV; Periman PO; Beggs D; Zhang Y; Townsend M
    Br J Haematol; 2008 Jul; 142(3):482-4. PubMed ID: 18510683
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial.
    Ferrero S; Pastore A; Scholz CW; Forstpointner R; Pezzutto A; Bergmann L; Trümper L; Finke J; Keller U; Ghione P; Passera R; Hiddemann W; Weigert O; Unterhalt M; Dreyling M
    Leukemia; 2016 Apr; 30(4):984-7. PubMed ID: 26242461
    [No Abstract]   [Full Text] [Related]  

  • 12. Mantle cell lymphoma in the orbital and adnexal region.
    Rasmussen P; Sjö LD; Prause JU; Ralfkiaer E; Heegaard S
    Br J Ophthalmol; 2009 Aug; 93(8):1047-51. PubMed ID: 19429588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
    Lenz G; Dreyling M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
    Krishnan A; Nademanee A; Fung HC; Raubitschek AA; Molina A; Yamauchi D; Rodriguez R; Spielberger RT; Falk P; Palmer JM; Forman SJ
    J Clin Oncol; 2008 Jan; 26(1):90-5. PubMed ID: 18025438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
    Kanaji N; Ishibashi K; Uno H; Hino N
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse aggressive lymphoma.
    Fisher RI; Miller TP; O'Connor OA
    Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete remission after treatment with single-agent ofatumumab in a patient with high-risk leukemic mantle-cell lymphoma.
    Hunstig F; Hammersen J; Kunert C; Petersen I; Merz H; Glaser A; Teichgräber U; Hochhaus A; La Rosée P
    J Clin Oncol; 2013 Jul; 31(19):e312-5. PubMed ID: 23690428
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant lymphoma of the lacrimal gland: a nation-based study.
    Rasmussen P; Ralfkiaer E; Prause JU; Sjö LD; Siersma VD; Heegaard S
    Arch Ophthalmol; 2011 Oct; 129(10):1275-80. PubMed ID: 21987669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment standards and emerging strategies in mantle cell lymphoma.
    Dreyling M; Hiddemann W;
    Hematology Am Soc Hematol Educ Program; 2009; ():542-51. PubMed ID: 20008239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple lymphomatous polyposis form is common but not specific for mantle cell lymphoma in the gastrointestinal tract.
    Okazaki K
    J Gastroenterol; 2004 Oct; 39(10):1023-4. PubMed ID: 15549463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.